Kari Hemminki

Active 1977–2025

274
Papers
41,126
Citations
113
h-index
266
i10-index

Citations

Citations per year for Kari Hemminki1977: 1 citations1978: 4 citations1979: 5 citations1980: 4 citations1981: 2 citations1982: 5 citations1983: 10 citations1984: 5 citations1985: 13 citations1986: 11 citations1987: 10 citations1988: 16 citations1989: 13 citations1990: 29 citations1991: 24 citations1992: 23 citations1993: 15 citations1994: 23 citations1995: 23 citations1996: 51 citations1997: 46 citations1998: 57 citations1999: 69 citations2000: 92 citations2001: 114 citations2002: 161 citations2003: 155 citations2004: 195 citations2005: 223 citations2006: 242 citations2007: 242 citations2008: 219 citations2009: 294 citations2010: 340 citations2011: 354 citations2012: 349 citations2013: 336 citations2014: 341 citations2015: 375 citations2016: 327 citations2017: 282 citations2018: 260 citations2019: 911 citations2020: 931 citations2021: 789 citations2022: 548 citations2023: 415 citations2024: 727 citations2025: 275 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,293 citing papers, 21.9% of this breakdownChina: 1,170 citing papers, 7.8% of this breakdownUnited Kingdom: 1,121 citing papers, 7.5% of this breakdownGermany: 909 citing papers, 6.1% of this breakdownItaly: 712 citing papers, 4.7% of this breakdownSweden: 683 citing papers, 4.5% of this breakdownFrance: 572 citing papers, 3.8% of this breakdownCanada: 495 citing papers, 3.3% of this breakdownNetherlands: 482 citing papers, 3.2% of this breakdownAustralia: 441 citing papers, 2.9% of this breakdownSpain: 417 citing papers, 2.8% of this breakdownDenmark: 338 citing papers, 2.3% of this breakdown
0%21.9%Other 29.2%

Fields

  • Medicine55.7%
  • Biochemistry, Genetics and Molecular Biology34.8%
  • Environmental Science2.6%
  • Immunology and Microbiology1.9%
  • Health Professions0.9%
  • Nursing0.6%
  • Other3.5%

Topics

  • Carcinogens and Genotoxicity Assessment2.4%
  • Genetic factors in colorectal cancer2.2%
  • Cancer Genomics and Diagnostics2.1%
  • Epigenetics and DNA Methylation1.8%
  • BRCA gene mutations in cancer1.7%
  • Genetic Associations and Epidemiology1.6%
  • Other88.2%

Coauthors

All papers

Open in search
  1. Metastatic sites and survival in lung cancer

    Authors: , , , , , , - Lung Cancer 2014 cited by 906

  2. Patterns of metastasis in colon and rectal cancer

    Authors: , , , - Scientific Reports 2016 cited by 950

  3. TERT Promoter Mutations in Familial and Sporadic Melanoma

    Authors: , , , , , , , , , , , - Science 2013 cited by 1,824

  4. Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland

    Authors: , , , , , , , , - New England Journal of Medicine 2000 cited by 4,137

  5. Metastatic spread in patients with gastric cancer

    Authors: , , , , - Oncotarget 2016 cited by 488

  6. Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , - Annals of Oncology 2022 cited by 197

  7. The epidemiology of metastases in neuroendocrine tumors

    Authors: , , , , - International Journal of Cancer 2016 cited by 376

  8. Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2017 cited by 248

  9. Update on genetic predisposition to colorectal cancer and polyposis

    Authors: , , , , , , , , , , , - Molecular Aspects of Medicine 2019 cited by 206

  10. Clinical landscape of cancer metastases

    Authors: , , , , - Cancer Medicine 2018 cited by 142

  11. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database

    Authors: , , - International Journal of Cancer 2002 cited by 560

  12. TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 335

  13. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Powles, Aslam Sohaib, O. Ståhl, Torgrim Tandstad, Guy C. Toner, A. Horwich - Annals of Oncology 2018 cited by 328

  14. miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma

    Authors: , , , , , - Non-coding RNA Research 2023 cited by 36

  15. The association between genetically elevated polyunsaturated fatty acids and risk of cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marc J. Gunter, George Davey Smith, Caroline L. Relton, Richard M. Martin, Nathan Tintle, Terri Rice, Iona Cheng, Mark A. Jenkins, Steve Gallinger, Alex J. Cornish, Amit Sud, Jayaram Vijayakrishnan, Margaret Wrensch, Mattias Johansson, Aaron D. Norman, Alison P. Klein, Alyssa Clay‐Gilmour, André Franke, Andres V Ardisson Korat, Bill Wheeler, Björn Nilsson, Caren E. Smith, Chew‐Kiat Heng, Ci Song, David Riadi, Elizabeth B. Claus, Eva Ellinghaus, Evgenia Ostroumova, Hosnijeh, Florent de Vathaire, Giovanni Cugliari, Giuseppe Matullo, Irene Oi‐Lin Ng, Jeanette E. Passow, Jia Nee Foo, Jiali Han, Jianjun Liu, Jill S. Barnholtz‐Sloan, Joellen M. Schildkraut, John M. Maris, Joseph L. Wiemels, Kari Hemminki, Keming Yang, Lambertus A Kiemeney, Lang Wu, Laufey T. Ámundadóttir, Marc‐Henri Stern, Marie-Christine Boutron, Mark M. Iles, Mark P. Purdue, Martin Stanulla, Melissa L. Bondy, Mia M. Gaudet, Lenha Mobuchon, Nicola J. Camp, Pak C. Sham, Pascal Guénel, Paul Brennan, Philip R. Taylor, Quinn T. Ostrom, Rachael Z. Stolzenberg‐Solomon, Rajkumar Dorajoo, Richard Houlston, Robert B. Jenkins, Sharon J. Diskin, Sonja I. Berndt, Spiridon Tsavachidis, Stephen J. Channock, Tabitha A. Harrison, Tessel E. Galesloot and 6 more - EBioMedicine 2023 cited by 52

  16. Functional dissection of inherited non-coding variation influencing multiple myeloma risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Niels Weinhold, Unnur Þorsteinsdóttir, Vijay G. Sankaran, Kāri Stefánsson, Richard S. Houlston, Björn Nilsson - Nature Communications 2022 cited by 30

  17. TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas

    Authors: , , , , , , , , , - Neuro-Oncology 2014 cited by 240

  18. Genome-wide association study identifies multiple susceptibility loci for multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hareth Nahi, Sven Nelander, Jolanta Nickel, Markus M. Nöthen, Þórunn Rafnar, Fiona M. Ross, Miguel Inácio da Silva Filho, Bhairavi Swaminathan, Hauke Thomsen, Ingemar Turesson, Annette Juul Vangsted, Ulla Vogel, Anders Waage, Brian A. Walker, Anna-Karin Wihlborg, Annemiek Broyl, Faith E. Davies, Unnur Þorsteinsdóttir, Christian Langer, Markus Hansson, Martin Kaiser, Pieter Sonneveld, Kāri Stefánsson, Gareth J. Morgan, Hartmut Goldschmidt, Kari Hemminki, Björn Nilsson, Richard S. Houlston - Nature Communications 2016 cited by 182

  19. 5‐Fluorouracil‐based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes

    Authors: , , , , , , , , - British Journal of Clinical Pharmacology 2010 cited by 124

  20. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions

    Authors: , , , - Arthritis & Rheumatism 2009 cited by 236

  21. Effect of autoimmune diseases on risk and survival in female cancers

    Authors: , , , , , - Gynecologic Oncology 2012 cited by 106

  22. Familial Risks for Type 2 Diabetes in Sweden

    Authors: , , , - Diabetes Care 2009 cited by 170

  23. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Jauch, Gareth J. Morgan, Kari Hemminki, Richard S. Houlston, Hartmut Goldschmidt - Nature Genetics 2013 cited by 164

  24. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ellinor Johnsson, Sigurður Y. Kristinsson, Ulf‐Henrik Mellqvist, Hareth Nahi, Douglas F. Easton, Paul D.P. Pharoah, Alison M. Dunning, Julian Peto, Federico Canzian, Anthony J. Swerdlow, Rosalind A. Eeles, Zsofia Kote‐Jarai, Kenneth Muir, Nora Pashayan, Jolanta Nickel, Markus M. Nöthen, Þórunn Rafnar, Fiona M. Ross, Miguel Inácio da Silva Filho, Hauke Thomsen, Ingemar Turesson, Annette Juul Vangsted, Niels Frost Andersen, Anders Waage, Brian A. Walker, Anna‐Karin Wihlborg, Annemiek Broyl, Faith E. Davies, Unnur Þorsteinsdóttir, Christian Langer, Markus Hansson, Hartmut Goldschmidt, Martin Kaiser, Pieter Sonneveld, Kāri Stefánsson, Gareth J. Morgan, Kari Hemminki, Björn Nilsson, Richard S. Houlston, Brian E. Henderson, Christopher A. Haiman, Sara Benlloch, Fredrick R. Schumacher, Ali Amin Al Olama, Sonja I. Berndt, David V. Conti, Fredrik Wiklund, Stephen J. Chanock, Victoria L. Stevens, Catherine M. Tangen, Jyotsna Batra, Judith Clements, Henrik Grönberg, Johanna Schleutker, Demetrius Albanes, Stephanie J. Weinstein, Alicja Wolk, Catharine West, Lorelei A. Mucci, Géraldine Cancel‐Tassin, Stella Koutros, Karina D. Sørensen, Eli Marie Grindedal, David E. Neal, Freddie C. Hamdy, Jenny Donovan, Ruth C. Travis, Robert J. Hamilton, Sue A. Ingles, Barry S. Rosenstein and 31 more - Nature Communications 2018 cited by 114